| Jacqueline Ann Cox, MD | |
|
1640 Cowles St, Suite 1, Fairbanks, AK 99701-5992 | |
| (907) 452-4768 | |
| (907) 452-1009 |
| Full Name | Jacqueline Ann Cox |
|---|---|
| Gender | Female |
| Speciality | Medical Oncology |
| Experience | 29 Years |
| Location | 1640 Cowles St, Fairbanks, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538153564 | NPI | - | NPPES |
| MD 6153 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 5565 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fairbanks Memorial Hospital | Fairbanks, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairbanks Cancer Care Physicians Pc | 3678627007 | 5 |
News Archive
PNP Therapeutics, Inc. — an early-stage Birmingham-based biopharmaceutical company created from research conducted at Southern Research Institute and The University of Alabama at Birmingham — today announced that several major objectives have been reached in the development of its therapeutic technology platform and proprietary products for the treatment of cancer.
Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, today announced another immuno-oncology collaboration that will evaluate abemaciclib (LY2835219), Lilly's cyclin-dependent kinase (CDK) 4 and 6 inhibitor, and Merck's KEYTRUDA (pembrolizumab) in a Phase I study across multiple tumor types.
When taken orally, trospium chloride not only helps control symptoms of overactive bladder systemically, but according to this study, it also may help control symptoms in the bladder itself when it comes into contact with the bladder walls.
Researchers at the National Cancer Institute have identified a gene that may play a role in breast cancer metastasis to the brain, according to a report in Molecular Cancer Research, a journal of the American Association for Cancer Research.
› Verified 8 days ago
| Entity Name | Fairbanks Cancer Care Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386759470 PECOS PAC ID: 3678627007 Enrollment ID: O20090819000239 |
News Archive
PNP Therapeutics, Inc. — an early-stage Birmingham-based biopharmaceutical company created from research conducted at Southern Research Institute and The University of Alabama at Birmingham — today announced that several major objectives have been reached in the development of its therapeutic technology platform and proprietary products for the treatment of cancer.
Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, today announced another immuno-oncology collaboration that will evaluate abemaciclib (LY2835219), Lilly's cyclin-dependent kinase (CDK) 4 and 6 inhibitor, and Merck's KEYTRUDA (pembrolizumab) in a Phase I study across multiple tumor types.
When taken orally, trospium chloride not only helps control symptoms of overactive bladder systemically, but according to this study, it also may help control symptoms in the bladder itself when it comes into contact with the bladder walls.
Researchers at the National Cancer Institute have identified a gene that may play a role in breast cancer metastasis to the brain, according to a report in Molecular Cancer Research, a journal of the American Association for Cancer Research.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacqueline Ann Cox, MD 1640 Cowles St, Suite 1, Fairbanks, AK 99701-5925 Ph: (907) 452-4768 | Jacqueline Ann Cox, MD 1640 Cowles St, Suite 1, Fairbanks, AK 99701-5992 Ph: (907) 452-4768 |
News Archive
PNP Therapeutics, Inc. — an early-stage Birmingham-based biopharmaceutical company created from research conducted at Southern Research Institute and The University of Alabama at Birmingham — today announced that several major objectives have been reached in the development of its therapeutic technology platform and proprietary products for the treatment of cancer.
Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, today announced another immuno-oncology collaboration that will evaluate abemaciclib (LY2835219), Lilly's cyclin-dependent kinase (CDK) 4 and 6 inhibitor, and Merck's KEYTRUDA (pembrolizumab) in a Phase I study across multiple tumor types.
When taken orally, trospium chloride not only helps control symptoms of overactive bladder systemically, but according to this study, it also may help control symptoms in the bladder itself when it comes into contact with the bladder walls.
Researchers at the National Cancer Institute have identified a gene that may play a role in breast cancer metastasis to the brain, according to a report in Molecular Cancer Research, a journal of the American Association for Cancer Research.
› Verified 8 days ago
Dr. James W Cagle Jr., D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1650 Cowles St, Suite 280 Nt, Fairbanks, AK 99701 Phone: 907-458-5178 Fax: 907-458-5180 | |
Jeffrey A Partnow, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1650 Cowles St, Fairbanks, AK 99701 Phone: 907-458-5178 Fax: 907-458-5180 | |
Dr. Arva Yahua Chiu, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1626 30th Ave, Fairbanks, AK 99701 Phone: 907-452-2637 Fax: 877-410-0865 | |
Keith B. Gianni, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1222 Well St, Suite One, Fairbanks, AK 99701 Phone: 907-452-6137 Fax: 907-452-6139 | |
David M Stieber, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1626 30th Avenue Ste 204, Fairbanks, AK 99701 Phone: 907-374-0432 Fax: 907-374-9932 | |
Dr. Daniel Kechker, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1650 Cowles St, Hospitalists Office, Fairbanks, AK 99701 Phone: 907-458-5178 Fax: 907-458-5180 | |
Dr. Romel C Wrenn, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1650 Cowles St, Fairbanks, AK 99701 Phone: 907-458-6450 Fax: 907-458-6430 |